Abstract
The current study evaluates the role of quantitative measurement of peripheral lymphocyte subsets, especially CD4+ helper T-cell recovery, in predicting transplant outcomes including overall survival (OS) and non-relapse mortality (NRM) after allogeneic stem cell transplantation. A total of 69 allogeneic recipients were included with following diagnoses: acute myeloid leukemia 42, acute lymphoblastic leukemia 5, chronic myeloid leukemia 15, non-Hodgkin's lymphoma 5 and high-risk myelodysplastic syndrome 2. The peripheral lymphocyte subset counts (CD3+ T cells, CD3+4+ helper T cells, CD3+8+ cytotoxic T cells, CD19+ B cells, and CD56+ natural killer cells) were measured at 3, 6 and 12 months. The CD4+ helper T-cell reconstitution at 3 months was strongly correlated with OS (P<0.0001), NRM (P=0.0007), and opportunistic infections (P=0.0108) at the cutoff value of 200 × 106/l CD4+ helper T cells. Rapid CD4+ helper T-cell recovery was also associated with a higher CD4+ helper T-cell transplant dose (P=0.006) and donor type (P<0.001). An early CD4+ helper T-cell recovery at 3 months correlated with a subsequent faster helper T-cell recovery until 12 months, yet not with B-cell recovery. In a multivariate analysis, rapid recovery of CD4+ helper T cells at 3 months was a favorable prognostic factor together with higher CD34+ cell transplant dose in terms of OS (P=0.001) and NRM (P=0.005).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Auletta JJ, Lazarus HM . Immune restoration following hematopoietic stem cell transplantation: an evolving target. Bone Marrow Transplant 2005; 35: 835–857.
Storek J, Gooley T, Witherspoon RP, Sullivan KM, Storb R . Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts. Am J Hematol 1997; 54: 131–138.
Antin JH . Immune reconstitution: the major barrier to successful stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 43–45.
Novitzky N, Davison GM, Hale G, Waldmann H . Immune reconstitution at 6 months following T-cell depleted hematopoietic stem cell transplantation is predictive for treatment outcome. Transplantation 2002; 74: 1551–1559.
Novitzky N, Davison GM . Immune reconstitution following hematopoietic stem-cell transplantation. Cytotherapy 2001; 3: 211–220.
Mackall CL, Granger L, Sheard MA, Cepeda R, Gress RE . T-cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic-derived versus thymic-independent progeny. Blood 1993; 82: 2585–2594.
Storek J, Witherspoon RP, Storb R . T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life. Bone Marrow Transplant 1995; 16: 413–425.
Dumont-Girard F, Roux E, van Lier RA, Hale G, Helg C, Chapuis B et al. Reconstitution of the T-cell compartment after bone marrow transplantation: restoration of the repertoire by thymic emigrants. Blood 1998; 92: 4464–4471.
Weinberg K, Blazar BR, Wagner JE, Agura E, Hill BJ, Smogorzewska M et al. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood 2001; 97: 1458–1466.
Flavell RA . The molecular basis of T cell differentiation. Immunol Res 1999; 19: 159–168.
Husmann LA, Bevan MJ . Cooperation between helper T cells and cytotoxic T lymphocyte precursors. Ann NY Acad Sci 1988; 532: 158–169.
Masur H, Kaplan JE, Holmes KK . Guidelines for preventing opportunistic infections among HIV-infected persons – 2002. Recommendations of the US Public Health Service and the Infectious Diseases Society of America. Ann Intern Med 2002; 137: 435–478.
Kaplan JE, Masur H, Holmes KK . Guidelines for preventing opportunistic infections among HIV-infected persons – 2002. Recommendations of the US Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep 2002; 51: 1–52.
Sohn SK, Kim DH, Kim JG, Lee NY, Suh JS, Lee KS et al. Transplantation outcome in allogeneic PBSCT patients according to a new chronic GVHD grading system, including extensive skin involvement, thrombocytopenia, and progressive-type onset. Bone Marrow Transplant 2004; 34: 63–68.
Kim DH, Kim JG, Sohn SK, Sung WJ, Suh JS, Lee KS et al. Clinical impact of early absolute lymphocyte count after allogeneic stem cell transplantation. Br J Haematol 2004; 125: 217–224.
Sohn SK, Kim JG, Chae YS, Kim DH, Lee NY, Suh JS et al. Large-volume leukapheresis using femoral venous access for harvesting peripheral blood stem cells with the Fenwal CS 3000 Plus from normal healthy donors: predictors of CD34+ cell yield and collection efficiency. J Clin Apheresis 2003; 18: 10–15.
Sohn SK, Kim JG, Sung WJ, Kim DH, Suh JS, Lee KS et al. Harvesting peripheral blood stem cells from healthy donors on 4th day of cytokine mobilization. J Clin Apheresis 2003; 18: 186–189.
Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825–828.
Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204–217.
Larosa F, Marmier C, Robinet E, Ferrand C, Saas P, Deconinck E et al. Peripheral T-cell expansion and low infection rate after reduced-intensity conditioning and allogeneic blood stem cell transplantation. Bone Marrow Transplant 2005; 35: 859–868.
de Vries E, van Tol MJ, van den Bergh RL, Waaijer JL, ten Dam MM, Hermans J et al. Reconstitution of lymphocyte subpopulations after paediatric bone marrow transplantation. Bone Marrow Transplant 2000; 25: 267–275.
Fallen PR, McGreavey L, Madrigal JA, Potter M, Ethell M, Prentice HG et al. Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients. Bone Marrow Transplant 2003; 32: 1001–1014.
Roux E, Dumont-Girard F, Starobinski M, Siegrist CA, Helg C, Chapuis B et al. Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity. Blood 2000; 96: 2299–2303.
Rocha B, Vassalli P, Guy-Grand D . Thymic and extrathymic origins of gut intraepithelial lymphocyte populations in mice. J Exp Med 1994; 180: 681–686.
Menendez P, Perez-Simon JA, Mateos MV, Caballero MD, Gonzalez M, San-Miguel JF et al. Influence of the different CD34+ and CD34− cell subsets infused on clinical outcome after non-myeloablative allogeneic peripheral blood transplantation from human leucocyte antigen-identical sibling donors. Br J Haematol 2002; 119: 135–143.
Storek J, Dawson MA, Maloney DG . Correlation between the numbers of naive T cells infused with blood stem cell allografts and the counts of naive T cells after transplantation. Biol Blood Marrow Transplant 2003; 9: 781–784.
Imamura M, Tsutsumi Y, Miura Y, Toubai T, Tanaka J . Immune reconstitution and tolerance after allogeneic hematopoietic stem cell transplantation. Hematology 2003; 8: 19–26.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, D., Sohn, S., Won, D. et al. Rapid helper T-cell recovery above 200 × 106/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation. Bone Marrow Transplant 37, 1119–1128 (2006). https://doi.org/10.1038/sj.bmt.1705381
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705381
Keywords
This article is cited by
-
Improved Vδ2+ T cells recovery correlates to reduced incidences of mortality and relapse in acute myeloid leukemia after hematopoietic transplantation
Annals of Hematology (2023)
-
T cell regeneration after immunological injury
Nature Reviews Immunology (2021)
-
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma
Bone Marrow Transplantation (2020)
-
Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting
Bone Marrow Transplantation (2019)
-
Selected biological issues affecting relapse after stem cell transplantation: role of T-cell impairment, NK cells and intrinsic tumor resistance
Bone Marrow Transplantation (2018)